1-208028046-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_025179.4(PLXNA2):c.5552A>G(p.Asn1851Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000553 in 1,608,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_025179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000923 AC: 14AN: 151712Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248676Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134414
GnomAD4 exome AF: 0.0000515 AC: 75AN: 1457064Hom.: 0 Cov.: 31 AF XY: 0.0000483 AC XY: 35AN XY: 724786
GnomAD4 genome AF: 0.0000923 AC: 14AN: 151712Hom.: 0 Cov.: 33 AF XY: 0.0000540 AC XY: 4AN XY: 74104
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1851 of the PLXNA2 protein (p.Asn1851Ser). This variant is present in population databases (rs141837222, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with PLXNA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2175547). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PLXNA2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
PLXNA2-related disorder Uncertain:1
The PLXNA2 c.5552A>G variant is predicted to result in the amino acid substitution p.Asn1851Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at